Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stem Cell Transplantation for Acute Burn
NCT01443689Phase 2Unknown
- Sponsor
- Beike Biotechnology
- Start
- Jul 2011
- Primary completion
- Mar 2013
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells, umbilical cord blood mononuclear cells in burn injury, sponsored by Beike Biotechnology. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cellsumbilical cord blood mononuclear cells
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT01443689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01443689.